Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
J Endourol. 2022 Jul;36(7):941-946. doi: 10.1089/end.2020.0151. Epub 2020 Dec 31.
To compare perioperative, functional, and oncologic outcomes between robot-assisted partial nephrectomy (RAPN) and laparoscopic partial nephrectomy (LPN) for renal hilar tumors. We retrospectively reviewed patients who underwent minimally invasive partial nephrectomy for renal hilar tumors at our institution between January 2014 and August 2018. The entire cohort was divided into two groups according to surgical approach: RAPN and LPN group. Perioperative, functional, and oncologic outcomes of the two groups were collected and compared. A total of 116 patients with renal hilar tumors were identified, including 52 patients who underwent RAPN and 64 patients who underwent LPN, respectively. Demographic baseline characteristics were similar in two groups. There were no differences between the RAPN and LPN groups for operative time, transfusion rate, conversion rate, surgical margin, perioperative complication, and hospital stay. Compared with the LPN group, the RAPN group was associated with significant less estimated blood loss (100 150 mL; < 0.001), shorter warm ischemia time (20.3 24.5 minutes; = 0.001), and higher direct cost ( < 0.001). Percentage of estimated glomerular filtration rate change at 6 months after surgery was lower in RAPN group than LPN group (10.4% 15.2%; = 0.020). No significant difference was observed between the two groups in terms of oncologic outcomes. For hilar tumors, both RAPN and LPN were safe and feasible surgical treatments. RAPN might be associated with superior perioperative outcomes (less estimated blood loss and shorter warm ischemia time) and better postoperative renal functional preservation. RAPN might be the preferred option when condition permits for renal hilar tumors.
比较机器人辅助部分肾切除术 (RAPN) 和腹腔镜部分肾切除术 (LPN) 治疗肾门肿瘤的围手术期、功能和肿瘤学结果。我们回顾性分析了 2014 年 1 月至 2018 年 8 月在我院接受微创肾门肿瘤部分肾切除术的患者。根据手术方式,将整个队列分为两组:RAPN 组和 LPN 组。收集并比较两组的围手术期、功能和肿瘤学结果。共纳入 116 例肾门肿瘤患者,其中 RAPN 组 52 例,LPN 组 64 例。两组患者的一般资料基线特征相似。RAPN 组与 LPN 组在手术时间、输血率、中转率、手术切缘、围手术期并发症和住院时间方面无差异。与 LPN 组相比,RAPN 组的估计失血量较少(100 150 ml;<0.001),热缺血时间较短(20.3 24.5 分钟;=0.001),直接费用较高(<0.001)。术后 6 个月估算肾小球滤过率变化率在 RAPN 组低于 LPN 组(10.4% 15.2%;=0.020)。两组在肿瘤学结果方面无显著差异。对于肾门肿瘤,RAPN 和 LPN 都是安全可行的手术治疗方法。RAPN 可能具有更好的围手术期结果(估计失血量少、热缺血时间短)和更好的术后肾功能保留。在条件允许的情况下,RAPN 可能是肾门肿瘤的首选治疗方法。